SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000899923-22-000079
Filing Date
2022-05-06
Accepted
2022-05-06 16:16:16
Documents
80
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mygn-20220331.htm   iXBRL 10-Q 1186098
2 EX-31.1 exhibit311-certificationof.htm EX-31.1 10538
3 EX-31.2 exhibit312-certificationof.htm EX-31.2 10554
4 EX-32.1 exhibit321-certificationpu.htm EX-32.1 6200
  Complete submission text file 0000899923-22-000079.txt   6479645

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mygn-20220331.xsd EX-101.SCH 42610
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mygn-20220331_cal.xml EX-101.CAL 77317
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mygn-20220331_def.xml EX-101.DEF 208562
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mygn-20220331_lab.xml EX-101.LAB 597302
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mygn-20220331_pre.xml EX-101.PRE 377924
74 EXTRACTED XBRL INSTANCE DOCUMENT mygn-20220331_htm.xml XML 1101215
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 22901266
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences